花旗上调ArriVent BioPharma目标价至40美元，肺癌数据获积极评价

24 6 月, 2025

One Min Read

11 Views

Last Update: 24 6 月, 2025

Written By

Other Articles

Previous

<div>New to Crypto? Analysts Say Skip Dogecoin (DOGE), Ruvi AI’s (RUVI) Audited Token At $0.015 Is a Safer and Smarter Bet</div>

Next

Best Crypto to Buy Now? Traders Predict Kaanch Will Outperform XRP and AVAX in the Next 18 Months

Related Posts

先消灭低价股！

1 Min Read

假期市场思考：A股还是美股？

1 Min Read

香港证券两日成交额破百亿！港股仍有市场？

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept